Melbourne-based Acrux has inked a deal potentially worth $367 million, giving US pharmaceutical giant Eli Lilly the right to sell its first-of-a-kind underarm sex-drive testosterone lotion. Under the terms of the agreement Eli Lilly will get worldwide rights to market the Axiron treatment - applied as an underarm cream - used in the treatment of testosterone deficiency in …
11
0
- To follow/ignore blogtactic, please sign in to your Ping.sg account.
Pongs:
There are no pongs yet. Maybe you can be the first to pong this post?
Comments:
There are no comments yet. Good opportunity for you to be the first!!11!1!!
Please login to leave a comment.


Maybe you can make it with your internet with blog